Clinical Trials on Pigmentation in Belgium

Total 11 results

Université Catholique de Louvain

Completed

EPR (Electron Paramagnetic Resonance) as Method of Non-invasive Characterization of Melanin Content in Skins With Different Phototypes

Skin Pigmentation | Free Radicals | Phototype | Magnetic Resonance

Belgium
Algemeen Ziekenhuis Maria Middelares

Unknown

Mesh Augmentation and Panniculectomy for the Treatment of Post-partum Abdominal Wall Insufficiency (PPAWI)

Mesh Augmentation

Belgium
Cliniques universitaires Saint-Luc- Université...
Geistlich Pharma AG

Recruiting

GBR With L-PRF Bone Block in Early Healing Phase After Extraction (LPRF-GBR)

Alveolar Ridge Augmentation

Belgium
University Hospital, Ghent

Completed

Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) (Koebner)

Vitiligo

Belgium
University Hospital, Ghent
Novartis

Completed

Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

Vitiligo Vulgaris

Belgium
University Hospital, Ghent
Novartis

Completed

Secukinumab in Active Non-segmental Vitiligo

Vitiligo | Secukinumab

Belgium
Clinuvel Europe Limited

Recruiting

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Xeroderma Pigmentosum

Belgium, Spain
Laboratoires Genévrier

Completed

Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

Vitiligo | Piebaldism

Belgium, France, Italy
Incyte Corporation

Recruiting

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

NonSegmental Vitiligo

Spain, Japan, United States, Poland, Canada, Belgium, Germany, Netherlands, France, Mexico
Pfizer

Completed

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Active Non-segmental Vitiligo

Spain, United States, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, Belgium, Italy
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Non-segmental Vitiligo

United States, Canada, Australia, Korea, Republic of, Switzerland, Germany, Spain, Chile, France, Israel, Netherlands, Japan, Belgium, Argentina, United Kingdom

Clinical Trials on Pigmentation in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations